Using the Bodyport Cardiac Scale to Predict Fluid Overload Events in Adults with Kidney Disease on Peritoneal Dialysis

What this Trial Is About

This research aims to explore how the Bodyport Cardiac Scale can predict worsening health events caused by fluid overload in people with kidney disease who are receiving peritoneal dialysis. The study focuses on measuring hemodynamic biomarkers, including individual signals and combined scores like the Congestion Index and a novel PD Index, to better understand fluid status in these patients. Participants will use the Bodyport Cardiac Scale device, which captures multiple physiological signals related to heart and fluid status. The study involves patients with end-stage kidney disease treated with automated peritoneal dialysis and monitored via the Vantive Sharesource Remote Patient Management Platform. The study does not involve changes to treatment but observes biomarker data over time. During the study, participants will be monitored for up to one year to evaluate the sensitivity of biomarker measurements in predicting fluid overload events. Researchers will assess dialysis-related events and track physiological signals from the device. Participants must be able to stand unassisted and will be involved in ongoing data collection without altering their usual care.

Sensor-based Congestion ALert for Events in Peritoneal Dialysis (SCALE-PD)